EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanoma

Sophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, Florian Hornsteiner, Annelie Kerstin Schäfer, Anastasia Prokopi, Janine Vierthaler, Antonia Resag, Daniela Ortner-Tobider, Vera Reinstadler, Irene Rigato, Berit Junger und 10 weitere

Journal for ImmunoTherapy of Cancer · 2026-06 · 14 (6) · e014808

DOI: 10.1136/jitc-2026-014808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 30.06.2026. Verfasst von Sophie Marie Dieckmann und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Dendritic Cells, Melanoma, Glutamate-Cysteine Ligase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Österreichischen Akademie der Wissenschaften.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic competition and nutrient restriction in the tumor microenvironment (TME) shape the immune infiltrate in tumors and subsequently tumor immunity. In this study we used the transgenic melanoma mouse model tg(Grm1)EPv, which spontaneously develops melanoma due to the ectopic expression of the metabotropic glutamate receptor 1 ( Grm1 ) in melanocytes to investigate if aberrant glutamate metabolism drives tumor formation and affects immune cell function.

Methods

We performed liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based metabolomic analyses and RNA sequencing on tumor-free and tumor-bearing tg(Grm1)EPv tissues to characterize metabolic alterations associated with tumor progression. Flow cytometry was used to examine changes in immune cell subsets within the TME. To assess the functional relevance of glutamate metabolism, we inhibited glutathione metabolism using L-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of glutamate-cysteine ligase that depletes cellular glutathione levels.

Results

LC-MS/MS-based metabolomic analyses and RNA sequencing revealed changes in glutamate and glutamine metabolism, a glycolytic shift (Warburg effect), and reduced ATP levels in advanced tumors compared with tumor-free tissue, suggesting respiratory chain dysfunction. These metabolic changes in the TME are advantageous for the tumor cells and unfavorable for immune cells, such as dendritic cells (DC). Indeed, flow cytometry analysis of myeloid subsets during tumor progression showed a decline in tumor-infiltrating conventional type 2 DC and macrophages, alongside an increase in neutrophil and monocyte populations in advanced lesions. Interference with glutamate metabolism using BSO induced immunogenic cell death, namely ferroptosis, in an tg(Grm1)EPv-derived cell line in vitro. Therefore, we evaluated the combination of this inhibitor with immunotherapy as a promising new approach for the treatment of tumors in the tg(Grm1)EPv mouse model. We observed that tumor growth could be delayed in vivo when BSO was combined with a therapy regimen boosting DC numbers and activation. This inhibition of tumor growth was supported by the infiltration of activated T cells.

Conclusion

Overall, our findings provide novel insights into the importance of combining metabolic intervention with immunotherapy for the treatment of patients with melanoma, particularly those bearing glutamate pathway-active or immunologically cold tumors. This knowledge can drive the design of novel therapeutic strategies for patients with cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsMelanomaGlutamate-Cysteine LigaseAnimalsMiceTumor MicroenvironmentMice, TransgenicGlutamic AcidHumansReceptors, Metabotropic GlutamateMetabolic ReprogrammingMetabolomics

Stichwörter der Autor:innen

Dendritic CellsImmunotherapyMelanomaTumor microenvironment - TME

Substanzen

Glutamate-Cysteine LigaseGlutamic AcidReceptors, Metabotropic Glutamate

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria.
  • Tyrolean Cancer Research Institute, Medical University of Innsbruck, Innsbruck, Austria.
  • Centre for Immunobiology and Infection, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Department of Dermatology, Venerelogoy and Allergology, Medical University of Innsbruck University Hospital for Dermatology and Venereology, Innsbruck, Austria.
  • Institute of Immunology, Dresden University of Technology, Dresden, Germany.

Förderung

  • Austrian Science Fund
  • Österreichischen Akademie der Wissenschaften

Zitieren

APA

Dieckmann, S. M., Tripp, C. H., Strandt, H., Hornsteiner, F., Schäfer, A. K., Prokopi, A., Vierthaler, J., Resag, A., Ortner-Tobider, D., Reinstadler, V., Rigato, I., Junger, B., Kleiter, A., Fotakis, G., Efremova, M., Trajanoski, Z., Boon, L., Chen, S., Bosserhoff, A. K., …, & Stoitzner, P. (2026). Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanoma. Journal for ImmunoTherapy of Cancer, 14(6), e014808. https://doi.org/10.1136/jitc-2026-014808

Vancouver

Dieckmann SM, Tripp CH, Strandt H, Hornsteiner F, Schäfer AK, Prokopi A, et al. Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanoma. Journal for ImmunoTherapy of Cancer. 2026;14(6):e014808. doi:10.1136/jitc-2026-014808

BibTeX
@article{Dieckmann2026,
  author = {Dieckmann, Sophie Marie and Tripp, Christoph H and Strandt, Helen and Hornsteiner, Florian and Schäfer, Annelie Kerstin and Prokopi, Anastasia and Vierthaler, Janine and Resag, Antonia and Ortner-Tobider, Daniela and Reinstadler, Vera and Rigato, Irene and Junger, Berit and Kleiter, Alexeja and Fotakis, Georgios and Efremova, Mirjana and Trajanoski, Zlatko and Boon, Louis and Chen, Suzie and Bosserhoff, Anja Katrin and Oberacher, Herbert and Finotello, Francesca and Stoitzner, Patrizia},
  title = {Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanoma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {6},
  pages = {e014808},
  doi = {10.1136/jitc-2026-014808}
}
Kostenlos starten →